2020
DOI: 10.22541/au.160676470.06549080/v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Multiple vertebral fractures after suspension of denosumab. A series of 56 cases.

Abstract: Background: Denosumab is a monoclonal antibody approved for the treat-ment of postmenopausal osteoporosis. The withdrawal of denosumab produc-es an abrupt loss of bone mineral density and may cause multiple vertebral fractures (MVF). Objective: To study the clinical, biochemical and densitometric characteristics in a large series of postmenopausal women who suffered MVF after deno-sumab withdrawal. Likewise, we try to identify those factors related to the presence of a greater number of vertebral fractures (VF… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 11 publications
0
1
0
Order By: Relevance
“…The reason why there are new fractures has not been clarified yet, but it has been suggested that the forces applied to the vertebrae change due to the infused orthopaedic cement 28,29,36 . Many case series reports have shown that in a short post-operative period new vertebrae fractures do occur [37][38][39][40][41] .…”
Section: Discussionmentioning
confidence: 99%
“…The reason why there are new fractures has not been clarified yet, but it has been suggested that the forces applied to the vertebrae change due to the infused orthopaedic cement 28,29,36 . Many case series reports have shown that in a short post-operative period new vertebrae fractures do occur [37][38][39][40][41] .…”
Section: Discussionmentioning
confidence: 99%